MENU
IMUX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Immunic (IMUX) Ownership - Who owns Immunic?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
1200 Avenue of the Americas
Phone
+1 332 255-9818
Employees
77
Web
https://www.imux.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
94.13M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
1.13M
Revenue
N/A
Risk (Beta)
1.87
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
IMUX
Capitalization
94.1M
P/E Ratio
N/A
Risk (Beta)
1.87
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
1.13M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
83.6M
P/B Ratio
2.28
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8K
Current Ratio
5.09
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
70M
Shares Outstanding - Current
90.1M
Total Liabilities
20.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-27.333
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceuticals and oral therapies for the treatment of chronic inflammatory and autoimmune diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1200 Avenue of the Americas
Phone
+1 332 255-9818
Employees
77
Web
https://www.imux.com